Yahoo Web Search

Search results

1. • Cantor Fitzgerald Comments on Skye Bioscience, Inc.’s FY2024 Earnings (NASDAQ:SKYE)

     ETF DAILY NEWS· 5 days ago

     Skye Bioscience, Inc. (NASDAQ:SKYE – Free Report) – Investment analysts at Cantor Fitzgerald raised their FY2024 earnings per share estimates for shares of Skye Bioscience in a research report ...

2. • Oracle Alpha Inc. Buys New Stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)

     ETF DAILY NEWS· 6 days ago

     Oracle Alpha Inc. purchased a new position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) during the fourth quarter, Holdings Channel reports. The fund purchased 693 ...

3. • Teachers Retirement System of The State of Kentucky Sells 1,245 Shares of Regeneron Pharmaceuticals,...

     ETF DAILY NEWS· 5 days ago

     Teachers Retirement System of The State of Kentucky cut its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 6.7% during the 4th quarter, according to the company in ...

4. • Insider Selling: Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) CEO Sells 9,064 Shares of Stock

     ETF DAILY NEWS· 7 days ago

     Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) CEO Leonard S. Schleifer sold 9,064 shares of the company’s stock in a transaction on Tuesday, June 11th. Following the completion ...

5. • Kapitalo Investimentos Ltda Purchases 130 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)

     ETF DAILY NEWS· 2 days ago

     Kapitalo Investimentos Ltda increased its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 118.2% in the fourth quarter, according to its most recent 13F filing with ...

6. • Skye Bioscience, Inc. to Post FY2024 Earnings of ($0.77) Per Share, Cantor Fitzgerald Forecasts...

     ETF DAILY NEWS· 5 days ago

     Skye Bioscience, Inc. (NASDAQ:SKYE – Free Report) – Analysts at Cantor Fitzgerald lifted their FY2024 earnings per share estimates for Skye Bioscience in a report released on Tuesday, June 11th ...

7. • Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Sold by Integrated Advisors Network LLC

     ETF DAILY NEWS· 22 hours ago

     Integrated Advisors Network LLC cut its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 6.2% during the fourth quarter, according to the company in its most recent ...

8. • JPMorgan Chase & Co. Raises Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target to $1,150.00

     ETF DAILY NEWS· 3 days ago

     Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its price target raised by JPMorgan Chase & Co. from $1,050.00 to $1,150.00 in a report issued on Monday, Benzinga reports. They currently ...

9. • Regeneron Pharmaceuticals (NASDAQ:REGN) Sets New 52-Week High Following Analyst Upgrade

     ETF DAILY NEWS· 4 days ago

     Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) shares reached a new 52-week high during mid-day trading on Monday after JPMorgan Chase & Co. raised their price target on the ...